突破中药欧盟注册障碍的关键因素分析

欧盟是中药国际化的桥梁,中药在欧盟成功注册具有重要的战略意义。该文简要回顾了10年来欧盟植物药政策的进展以及品种的批准情况,系统研究了欧盟植物药注册的政策法规,分析了一些中药欧盟注册的典型案例,重点从注册类别、审批程序、审批部门、申报品种、申报企业5个方面分析影响注册成败的关键因素,并提出了突破欧盟注册障碍的相应对策与建议,以期为我国中药在欧盟成功注册和实施中药国际化战略提供参考和借鉴。

Key elements to break through registration barriers on traditional Chinese medicine in EU

The EU is an international bridge of traditional Chinese medicine (TCM), and TCM in EU is of strategic importance. In this paper the progress on policies and regulations and approved products of herbal medical products in EU in 10 years were briefly reviewed, registration regulations were systematically studied and some typical cases were analyzed. To provide reference for successful registration of TCM in EU and implementation of international strategy of TCM, five key elements (i.e. registration classification, approval procedure, approval authority, application product and application enterprise) to break through the registration barriers on TCM in EU were putted forwards correspondingly.